FDA Product Code JDO: Device, Fixation, Proximal Femoral, Implant
Leading manufacturers include Synthes (Usa), Biomet, Inc. and Smith & Nephew, Inc..
23
Total
23
Cleared
115d
Avg days
1978
Since
Declining activity -
0 submissions in the last 2 years
vs 2 in the prior period
FDA 510(k) Cleared Device, Fixation, Proximal Femoral, Implant Devices (Product Code JDO)
23 devices
Cleared
Apr 18, 2023
OsteoCentric Integrated Hip Fastener System
OsteoCentric Technologies
Orthopedic
29d
Cleared
Sep 29, 2022
Smith & Nephew, Inc. Plates and Screws Systems: EVOS, Peri-Loc, D-Rad, TC-100, VLP Mini-Mod, Compression Hip Screw (CHS), CONQUEST FN, and cannulated screws
Smith & Nephew, Inc.
Orthopedic
367d
Cleared
Apr 30, 2021
OsteoCentric Integrated Hip Fastener System
Osteocentric Technologies D.B.A. Osteocentric Trauma
Orthopedic
91d
Cleared
Feb 28, 2020
CONQUEST FN
Smith & Nephew, Inc.
Orthopedic
121d
Cleared
Feb 07, 2018
THP Hip Fracture Plating System
Biomet, Inc.
Orthopedic
51d
Cleared
Apr 04, 2014
TSP HIP FRACTURE PLATING SYSTEM
Biomet, Inc.
Orthopedic
91d
Cleared
Apr 10, 2008
INTERTAN CHS LOCKING PLATE SYSTEM PROX FEM PLATES/SCREW
Smith & Nephew, Inc.
Orthopedic
51d
Cleared
Jul 17, 1998
SYNTHES (USA) DHS HELIX SYSTEM
Synthes (Usa)
Orthopedic
59d
Cleared
Jan 09, 1997
SYNTHES (USA) DDHS/DCS SYSTEM MODIFICATION
Synthes (Usa)
Orthopedic
76d
Cleared
Mar 08, 1996
TITANIUM LIMITED CONTACT DYNAMIC HIP SCREW PLATE (TILC-DHS)
Synthes (Usa)
Orthopedic
219d
Cleared
Jul 17, 1995
SYNTHES (USA) [SYNTHES] POINT CONTACT FIXATOR PLATE [PC-FIX]
Synthes (Usa)
Orthopedic
84d
Cleared
Jun 22, 1993
SYNTHES LIMITED CONTACT-DYNAMIC HIP SCREW IMPLANT
Synthes (Usa)
Orthopedic
336d
Cleared
Mar 05, 1981
PROXIMAL FERMORAL HIP REPLACEMENT
Biomet, Inc.
Orthopedic
34d
Cleared
Aug 21, 1978
BIOMET CONCENTRIC HEX SCREW
Biomet, Inc.
Orthopedic
11d
Cleared
Mar 15, 1978
NAIL, MASSIE II
Howmedica Corp.
Orthopedic
37d
About Product Code JDO - Regulatory Context
510(k) Submission Activity
23 total 510(k) submissions under product code JDO since 1978, with 23 receiving FDA clearance (average review time: 115 days).
Submission volume has declined in recent years - 0 submissions in the last 24 months compared to 2 in the prior period.